October 17, 2017 8:38 AM ET


Company Overview of D&A Pharma SAS

Company Overview

D&A Pharma SAS, a pharmaceutical company, engages in the research, development, production, and marketing of drugs to treat patients suffering from addictions, such as alcohol, heroin, and cocaine in France and internationally. It offers phyto-orogranules, a dry formulation in pellets with a very fast absorption in the mouth; and baume agathol, rocgel, calprimum, and trolovol. The company was founded in 2006 and is based in Paris, France.

79 rue de Miromesnil

Paris,  75008


Founded in 2006


33 1 53 04 41 30


33 1 42 94 20 18

Key Executives for D&A Pharma SAS

Chief Executive Officer
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
4P Pharma Europe
A.T.O. ZIZINE S.A.S Europe
Advicenne Pharma Europe
Aerocid Europe
AG Pharma Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact D&A Pharma SAS, please visit www.da-pharma.fr. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.